Neurocrine Biosciences, Inc. (NBIX)
153.04
+0.47
(+0.31%)
USD |
NASDAQ |
Aug 24, 16:00
153.04
0.00 (0.00%)
After-Hours: 18:24
Neurocrine Biosciences 1 Year Total Returns (Daily) : 12.78% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 12.78% |
| August 20, 2026 | 14.79% |
| August 19, 2026 | 17.11% |
| August 18, 2026 | 15.84% |
| August 17, 2026 | 16.25% |
| August 14, 2026 | 16.30% |
| August 13, 2026 | 14.59% |
| August 12, 2026 | 21.41% |
| August 11, 2026 | 30.62% |
| August 10, 2026 | 31.93% |
| August 07, 2026 | 30.10% |
| August 06, 2026 | 24.44% |
| August 05, 2026 | 25.79% |
| August 04, 2026 | 29.69% |
| August 03, 2026 | 28.95% |
| July 31, 2026 | 30.08% |
| July 30, 2026 | 35.64% |
| July 29, 2026 | 34.73% |
| July 28, 2026 | 36.74% |
| July 27, 2026 | 33.50% |
| July 24, 2026 | 33.52% |
| July 23, 2026 | 30.29% |
| July 22, 2026 | 30.09% |
| July 21, 2026 | 35.82% |
| July 20, 2026 | 31.04% |
| Date | Value |
|---|---|
| July 17, 2026 | 27.42% |
| July 16, 2026 | 28.52% |
| July 15, 2026 | 31.10% |
| July 14, 2026 | 27.31% |
| July 13, 2026 | 30.45% |
| July 10, 2026 | 31.27% |
| July 09, 2026 | 35.23% |
| July 08, 2026 | 38.45% |
| July 07, 2026 | 38.79% |
| July 06, 2026 | 34.85% |
| July 02, 2026 | 34.67% |
| July 01, 2026 | 31.07% |
| June 30, 2026 | 34.09% |
| June 29, 2026 | 35.54% |
| June 26, 2026 | 33.00% |
| June 25, 2026 | 28.49% |
| June 24, 2026 | 29.55% |
| June 23, 2026 | 28.33% |
| June 22, 2026 | 27.71% |
| June 18, 2026 | 24.33% |
| June 17, 2026 | 27.32% |
| June 16, 2026 | 25.14% |
| June 15, 2026 | 28.23% |
| June 12, 2026 | 27.80% |
| June 11, 2026 | 31.04% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Amarin Corp. Plc | -10.94% |
| Liquidia Corp. | 151.4% |
| Incyte Corp. | 47.71% |
| Krystal Biotech, Inc. | 137.9% |
| Halozyme Therapeutics, Inc. | 51.05% |